Pfizer Company
Discover the commonalities and differences between biologics vs. biosimilars — especially when it comes to cost.
Invests into
Connections from
Funding Status:
Post-IPO Debt
Industry:
Global Health
Estimated Revenue:
US$58.5 billion
Technology:
Biotechnology
Acquisitions Number:
Made Acquisitions
Number Of Exists:
19
Headquarters:
USA
Total Funding:
31000000000
Last Funding Date:
2023-05-16
Last Funding Type:
Post-IPO Debt
Investor Type:
Corporate Venture Capital
Employee Number:
10001+
Investors Number:
44
Investment Stage:
Undisclosed
Zip:
NA
Founded Date:
1849-01-01